My Portfolio
My Watchlists
Profile & Performance
Smart Portfolio
Find & Follow Experts
Top Lists
Top Experts
Make Better, Data Driven Investment Decisions
TipRanks tools are all you need to make data-driven investment decisions, conduct comprehensive stock research, find new investment ideas, analyze your portfolio, and follow the best-performing Wall Street experts.
About Us
Plans & Pricing
ANI Pharmaceuticals Inc (ANIP)
NASDAQ:ANIP
ANIP nasdaq
United States
ANI Pharmaceuticals

ANI Pharmaceuticals Stock Analysis & Ratings

ANI Pharmaceuticals Stock Analysis Overview

Smart Score
7
Neutral
1
2
3
4
5
6
7
8
9
10
Learn more about TipRanks Smart Score
The ANI Pharmaceuticals stock analysis is based on the TipRanks Smart Score which is derived from 8 unique data sets including Analyst recommendations, Crowd Wisdom, Hedge Fund Activity, Media Sentiment and multiple Technical stock factors. The Smart Score is a quantitative, data-driven rating system and does not include human intervention.

Stock Chart

ANIP

ANIP Stock Stats

Previous Close$40.77
Open$41.44
Bid39 x 1
Ask46 x 3
Today’s Range$40.07 - $42.34
52-Week Range$26.10 - $60.23
Volume204.28K
Average Volume150.64K
Market Cap$597.57M
Beta1.21
P/E Ratio-22.3
EPS-1.83
Earnings DateMar 03, 2022

Company Description

ANI Pharmaceuticals Inc

ANI Pharmaceuticals, Inc. is a pharmaceutical company, which engages in developing, manufacturing, and marketing branded and generic prescription pharmaceuticals. Its areas of product development include narcotics, oncolytics, hormones and steroids, and complex formulations involving extended release and combination products. The company was founded on August 29, 1996 and is headquartered in Baudette, MN.
Sector
Healthcare
Industry
Drug Manufacturers
CEO
Nikhil Lalwani
Employees
369
ISIN
US00182C1036
Address
210 Main Street West, Baudette, MN, 56623, US

Financials


P/E Ratio Range

The price to earnings ratio. This is used by investors to assess a stock’s market price relative to its earnings.

ANIP FAQ

What was ANI Pharmaceuticals’s price range in the past 12 months?
ANI Pharmaceuticals lowest stock price was $26.10 and its highest was $60.23 in the past 12 months.
    What is ANI Pharmaceuticals’s market cap?
    ANI Pharmaceuticals’s market cap is $597.57M.
      What is ANI Pharmaceuticals’s price target?
      The average price target for ANI Pharmaceuticals is $67.50. This is based on 2 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
      The highest analyst price target is $70.00 ,the lowest forecast is $65.00. The average price target represents 60.98% Increase from the current price of $41.93.
        What do analysts say about ANI Pharmaceuticals?
        ANI Pharmaceuticals’s analyst rating consensus is a ‘Moderate Buy. This is based on the ratings of 2 Wall Streets Analysts.
          When is ANI Pharmaceuticals’s upcoming earnings report date?
          ANI Pharmaceuticals’s upcoming earnings report date is Mar 03, 2022 which is in 93 days.
            How were ANI Pharmaceuticals’s earnings last quarter?
            ANI Pharmaceuticals released its earnings results on Nov 01, 2021. The company reported $1.01 earnings per share for the quarter, beating the consensus estimate of $0.7 by $0.31.
              Is ANI Pharmaceuticals overvalued?
              According to Wall Street analysts ANI Pharmaceuticals’s price is currently Undervalued.
                Does ANI Pharmaceuticals pay dividends?
                ANI Pharmaceuticals does not currently pay dividends.
                What is ANI Pharmaceuticals’s EPS estimate?
                ANI Pharmaceuticals’s EPS estimate for its next earnings report is not yet available.
                How many shares outstanding does ANI Pharmaceuticals have?
                ANI Pharmaceuticals has 14,250,000 shares outstanding.
                  What happened to ANI Pharmaceuticals’s price movement after its last earnings report?
                  ANI Pharmaceuticals reported an EPS of $1.01 in its last earnings report, beating expectations of $0.7. Following the earnings report the stock price went up 52.087%.
                    Which hedge fund is a major shareholder of ANI Pharmaceuticals?
                    Among the largest hedge funds holding ANI Pharmaceuticals’s share is Hussman Strategic Advisors Inc. It holds ANI Pharmaceuticals’s shares valued at N/A.

                      What's Included in PREMIUM?
                      Make informed decisions based on Top Analysts' activity
                      Know what industry insiders are buying
                      Get actionable alerts from top Wall Street Analysts
                      Find out before anyone else which stock is going to shoot up
                      Get powerful stock screeners & detailed portfolio analysis